Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

New alcohol risk genes in Caucasians

June 2, 2020

A new oxime that crosses the blood-brain barrier as a treatment for organo-phosphate poisoning

May 25, 2020

New MVP against SVMP

May 11, 2020

Antibiotics affect oxycodone effects

May 8, 2020

Platelets play role in Tylenol toxicity

April 30, 2020

Dopamine has epigenetic role in addiction

April 14, 2020

IXT-v100 vaccine decreases meth-taking and -seeking behaviors in vivo

April 8, 2020

New animal model more accurate for assessing nerve agent poisoning countermeasures

March 31, 2020

Heparan sulfate DAMPens acetaminophen toxicity

March 27, 2020

Paraoxonase 1 gene therapy offers long-term protection against lethal doses of nerve agents in mice

Feb. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...